Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 108
Filtrar
1.
Eur Rev Med Pharmacol Sci ; 27(16): 7738-7748, 2023 08.
Artigo em Inglês | MEDLINE | ID: mdl-37667952

RESUMO

OBJECTIVE: The aim of this study was to develop an initial valid tool to measure attitudes toward cancer-related cognitive changes. SUBJECTS AND METHODS: After revising the literature, three main dimensions were hypothesized. Eight judges were contacted to obtain content validity evidence. A robust Exploratory Factor Analysis (EFA) was performed via a parallel analysis with an Unweighted Least Squares (ULS) estimator and polychoric correlations. The results were crossed with sociodemographic variables to find possible statistical differences and estimate the size effect. Analysis was performed in the software Factor and the statistical package R. RESULTS: A sample of 374 participants was obtained, involving oncology patients, their caregivers, and people from the general community. A statistical fit was found in two dimensions: Awareness and Judgments [root mean squared error of approximation (RMSEA) = 0.042, standardized root mean square residual (SRMR) = 0.02, comparative fit index (CFI) = 0.99, Tucker-Lewis index (TLI) = 0.98] with a moderate correlation between them (r = 0.612). Optimal reliability indices were obtained for the total scale and its dimensions. No real statistical difference was found between sociodemographic variables; the interpretation norms were established via the quartiles. CONCLUSIONS: The first attempt to measure the construct of interest was developed with two primary validity evidence based on the content and its internal structure. This instrument could help strengthen the prevention of cancer-related cognitive changes. More research is needed to adhere more valid evidence to the scale.


Assuntos
Oncologia , Neoplasias , Humanos , Colômbia , Reprodutibilidade dos Testes , Software , Cognição
2.
Niger J Clin Pract ; 25(1): 110-113, 2022 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-35046204

RESUMO

INTRODUCTION: LipStaT® lip repositioning surgery using a diode laser for the management of gummy smiles offers promising and consistent long-term results. OBJECTIVE: To describe the technique through a clinical case, including its indications, preoperative evaluation, surgical approach, and recommendations after the intervention. CASE REPORT: A 29-year-old woman with excessive gingival display (EGD) of 4 mm when smiling; the LipStaT® technique was performed with a 940 nm diode laser to remove a strip of mucosa by ablating the epithelial tissue, and thus, achieve aesthetic, harmonic and functional results. The inflammation and postoperative pain were treated with the diode laser assisted lymphatic drainage technique. After follow-up, a satisfactory tissue response was observed, and no pain or inflammation was reported. CONCLUSION: The use of a 940 nm diode laser proved to be an effective treatment option for patients with a gummy smile, allowing control of intraoperative bleeding and improvement of the healing process obtaining predictable long-term results.


Assuntos
Estética Dentária , Lábio , Adulto , Feminino , Gengiva , Gengivectomia , Humanos , Lasers Semicondutores/uso terapêutico , Sorriso
4.
Dalton Trans ; 49(17): 5416-5419, 2020 May 07.
Artigo em Inglês | MEDLINE | ID: mdl-32250374

RESUMO

An easy, direct and room temperature silicon-carbon bond activation is reported. The reaction of [RhCl(coe)2]2 with the silane Si(Me)2(o-C6H4SMe)2 in the presence of an halide extractor provokes a Si-CH3 bond cleavage yielding a cationic silyl-methyl-Rh(iii). In contrast, if the reaction is performed using the Rh(i) bis-alkene dimers, [RhCl(cod)]2 or [RhCl(nbd)]2, the Si-CH3 bond activation does not occur.

5.
Spectrochim Acta A Mol Biomol Spectrosc ; 227: 117570, 2020 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-31669938

RESUMO

Phenolic compounds (PC) have been proposed as natural antioxidant agents that protect cells against oxidative stress-related diseases. Nonetheless, their low bioavailability forecasts controversy about mechanisms on their in vivo scavenging activity against reactive oxygen species (ROS). It has been proposed that PC reduce directly ROS concentration. An alternative or complementary action of PC could be the activation of the cell's antioxidant pathway, involving the regulation of gene expression, like that initiated by the Nrf2 transcription factor. To date there is not enough experimental data to support or discard this possibility. In the present study, we evaluated the use of several PC to prevent peroxidation of macromolecules and to elicit the activation of the Nrf2 transcription factor in H2O2-stresed IEC-6 enterocytic cell line. Synchrotron microspectroscopy demonstrated that PC compounds protected proteins, lipids and nucleic acids against oxidation induced by H2O2. Immunofluorescence results showed that treatment with quercetin (Qc), catechin (Cat) and capsaicin (Cap) induced the translocation of Nrf2 into the nucleus, at the same level as did H2O2 treatment, thus mimicking the action of the endogenous cell response to peroxidation. Even though the detailed mechanism still needs to be elucidated, we demonstrated the activation of Nrf2 by PCs in response to oxidative stress.


Assuntos
Antioxidantes/farmacologia , Capsaicina/farmacologia , Catequina/farmacologia , Estresse Oxidativo/efeitos dos fármacos , Quercetina/farmacologia , Animais , Linhagem Celular , Peróxido de Hidrogênio/metabolismo , Fator 2 Relacionado a NF-E2/metabolismo , Ratos , Espectroscopia de Infravermelho com Transformada de Fourier
6.
Radiología (Madr., Ed. impr.) ; 60(6): 465-475, nov.-dic. 2018. ilus, tab
Artigo em Espanhol | IBECS | ID: ibc-175323

RESUMO

El plasma rico en plaquetas (PRP) es un preparado con fines terapéuticos cada vez más aceptado en diversas patologías musculoesqueléticas, debido a su teórico potencial para reparar tejidos con baja capacidad curativa. Se han realizado diversos ensayos clínicos aleatorizados que investigan la capacidad del PRP para la reparación de tendones, ligamentos, músculos y cartílago. Hasta la fecha existe evidencia 1A que apoya su uso para la epicondilitis lateral, la osteoartritis de rodilla, la fascitis plantar y tendinopatías del manguito rotador, y evidencia 1B en la tendinopatía del tendón rotuliano y la osteoartritis de cadera. Estudios retrospectivos, de cohortes y series de casos describen resultados prometedores del PRP para el tratamiento de otras patologías musculoesqueléticas. Al ser sus efectos secundarios menores que los de los grupos controles hacen que sea un tratamiento considerado como prácticamente inocuo y cada vez más usado. Son necesarios nuevos ensayos clínicos aleatorizados para establecer futuras indicaciones y confirmar su efectividad y seguridad


Platelet-rich plasma (PRP) is a preparation for therapeutic purposes that is increasingly accepted for various musculoskeletal disorders, due to its theoretical potential to repair tissues with poor healing capacity. Several randomised clinical trials have investigated the capacity of PRP to repair tendons, ligaments, muscles and cartilage, and to date there is level 1a evidence to support its use for lateral epicondylitis, osteoarthritis of the knee, plantar fasciitis and rotator cuff tendinopathy; and level 1b for patellar tendinopathy and osteoarthritis of the hip. Retrospective cohort studies and case series describe promising results with PRP for treating other musculoskeletal disorders. Since its side effects are fewer than those of the control groups, the treatment is considered practically harmless and is being increasingly used. Further randomised clinical trials are necessary to establish future indications, and to confirm effectiveness and safety


Assuntos
Humanos , Plasma Rico em Plaquetas , Traumatismos dos Tendões/terapia , Entorses e Distensões/terapia , Fraturas de Cartilagem/terapia , Resultado do Tratamento , Tendinopatia/terapia , Lesões do Manguito Rotador/terapia , Fasciíte Plantar/terapia
7.
Radiologia (Engl Ed) ; 60(6): 465-475, 2018.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-30274850

RESUMO

Platelet-rich plasma (PRP) is a preparation for therapeutic purposes that is increasingly accepted for various musculoskeletal disorders, due to its theoretical potential to repair tissues with poor healing capacity. Several randomised clinical trials have investigated the capacity of PRP to repair tendons, ligaments, muscles and cartilage, and to date there is level 1a evidence to support its use for lateral epicondylitis, osteoarthritis of the knee, plantar fasciitis and rotator cuff tendinopathy; and level 1b for patellar tendinopathy and osteoarthritis of the hip. Retrospective cohort studies and case series describe promising results with PRP for treating other musculoskeletal disorders. Since its side effects are fewer than those of the control groups, the treatment is considered practically harmless and is being increasingly used. Further randomised clinical trials are necessary to establish future indications, and to confirm effectiveness and safety.


Assuntos
Doenças Musculoesqueléticas/terapia , Plasma Rico em Plaquetas , Humanos
10.
Ars pharm ; 58(4): 145-154, oct.-dic. 2017. graf
Artigo em Inglês | IBECS | ID: ibc-172557

RESUMO

Objectives. To make the synthesis of halogenated derivatives on the nitrogenous base and their respective acyl ester and amide type derivatives for all hydroxyl and amine groups of the uridine and cytarabine nucleosides, and evaluate cytotoxicity against breast cancer cell line. Methods. First, it was accomplished the halogenation reaction on the 5-position of the nitrogenous base, subsequently, the ester and amide derivatives were performed for all hydroxyl and amine group present in the nucleosides. Besides, the uridine acetonide derivatives as prepared by acid catalysis. The products were characterized by nuclear magnetic resonance spectroscopy (1H RMN y 13C RMN) and mass spectrometry in positive mode by direct injection. Derivatives were evaluated in Chinese hamster ovary (CHO-K1) and human breast cancer (MCF-7) cell lines. Results. The four derivatives were obtained with chlorine and bromine for the uridine and cytarabine, respectively, their respective per-acetylated derivatives, the per-acetylated nucleoside and the uridine. acetonide; the compounds were obtained with efficiency over 90%. The per-acetylated nucleosides and the halogenated and per-acetylated derivatives did not show inhibitory effects on cell viability in MCF-7 cell line. However, the per-acetylated and halogenated derivatives presented a higher cytotoxic activity than their respective per-acetylated nucleoside. The uridine 3',4'-acetonide showed a significant cytotoxicity on both cell lines. Conclusions. The per-acetylated nucleoside, and the respective halogenated derivatives with chlorine and bromine were obtained with high yields, nevertheless, these compounds did not exhibit a significant anti-proliferative activity (p˂0.05), possibly due to a low intra-cellular activation


Objetivos: Sintetizar derivados halogenados sobre la base nitrogenada, sus respectivos derivados tipo éster o amida de todos los grupos hidroxilo y amina presentes en los nucleósidos uridina y citarabina, y evaluar su actividad citotóxica sobre una línea celular de cáncer de mama. Metodología: primero se realizó la reacción de halogenación en la posición 5 de la base nitrogenada, posteriormente se formaron los ésteres y amidas de todos los grupos hidroxilos y amino presentes en los nucleósidos. Además, se preparó el derivado acetónido con catálisis ácida. Los compuestos se caracterizaron por espectroscopía de resonancia magnética nuclear (RMN 1H y RMN 13C) y espectrometría de masas por inyección directa en modo positivo. Los derivados se evaluaron sobre líneas celulares de tumor de Ovario de Hámster Chino (CHO) y de cáncer de mamá (MCF-7). Resultados: Se obtuvieron 4 derivados mono-halogenados con cloro y bromo de la uridina y citarabina, respectivamente, sus respectivos derivados per-acetilados, los nucleósidos per-acetilados y el acetónido de la uridina; los compuestos se obtuvieron con rendimientos superiores a 90%. Los nucleósidos per-acetilados, y los derivados per-acetilados y halogenados no exhibieron una inhibición significativa de la viabilidad celular en ambas líneas celulares, sin embargo, de estos, los derivados per-acetilados y halogenados presentaron mayor actividad citotóxica que los respectivos nucleósidos per-acetilados. El derivado acetónido de la uridina mostró citotoxicidad significativa sobre ambas líneas celulares. Conclusiones: se obtuvieron los nucleósidos per-acetilados y los respectivos derivados clorados y bromados de estos, con rendimientos altos, sin embargo, estos compuestos no exhibieron una actividad anti-proliferativa significativa (p ˂ 0,05), posiblemente debido a una baja activación intra-celular de los nucleósidos


Assuntos
Animais , Neoplasias da Mama/tratamento farmacológico , Nucleosídeos/farmacologia , Neoplasias Ovarianas/tratamento farmacológico , Uridina/uso terapêutico , Citarabina/uso terapêutico , Halogenação , Espectroscopia de Ressonância Magnética/métodos , Cricetulus , Ensaios de Seleção de Medicamentos Antitumorais/métodos
12.
J Pain Res ; 10: 1777-1786, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28794657

RESUMO

BACKGROUND: The role of dopaminergic system in the development of rheumatoid arthritis-related pain, a major symptom in this disease, has not been explored. Therefore, the anti-nociceptive effect of mazindol, a dopamine uptake inhibitor, was evaluated in a model of complete Freund's adjuvant (CFA)-induced arthritis. Furthermore, as studies have shown that the dopaminergic system regulates bone metabolism, the effect of mazindol on bone mass and microarchitecture was determined. METHODS: Adult ICR male mice received intra-articular injections of either CFA or saline into the right knee joint every week. Spontaneous pain-like behaviors (flinching and guarding) and locomotor activity were assessed at day 26 post-first CFA, following which, a single intraperitoneally (i.p.) administered dose of mazindol was given (1, 3 and 10 mg/kg). Then, the antinociceptive effect of a repeated administration of 3 mg/kg mazindol (daily, i.p.; day 15-day 26) was evaluated. Additionally, at day 26, the participation of D1-like, D2-like or opioid receptors in the antinociceptive effect of mazindol was evaluated. The effect of mazindol on bone density and microarchitecture was evaluated by micro-computed tomography. RESULTS: Acute administration of mazindol decreased the spontaneous pain-like behaviors in a dose-dependent manner without reducing the knee edema. However, mazindol at 10 mg/kg significantly increased the locomotor activity; therefore, 3 mg/kg mazindol was used for further studies. Repeated administration of 3 mg/kg mazindol significantly decreased the pain-like behaviors without modifying locomotor activity. The antinociceptive effect of mazindol was blocked by administration of a D2-like receptor antagonist (haloperidol), but not by administration of D1-like receptor antagonist (SCH 23390) or an opioid receptor antagonist (naloxone). Repeated administration of mazindol did not significantly modify the density and microarchitecture of periarticular bone of the arthritic and nonarthritic knee joints. CONCLUSION: Results suggest that mazindol via D2-like receptors has an antinociceptive role in mice with CFA-induced knee arthritis without modifying the bone health negatively.

15.
Parkinsons Dis ; 2017: 9641392, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28280646

RESUMO

Parkinson's disease (PD) is a neurodegenerative condition, which compromises the motor functions and causes the alteration of some executive brain functions. The presence of changes in cognitive symptoms in PD could be due to the procedure of deep brain stimulation (DBS). We searched in several databases for studies that compared performance in executive function tests before and after the DBS procedure in PE and then performed a meta-analysis. After the initial search, there were 15 articles that specifically evaluated the functions of verbal fluency, working memory, cognitive flexibility, abstract thinking, and inhibition. It was found that there were differences in the evaluation of the cognitive functions in terms of the protocols, which generated heterogeneity in the results of the meta-analysis. Likewise, a tendency to diminish functions like verbal fluency and inhibition was found, being this consistent with similar studies. In the other functions evaluated, no difference was found between pre- and postsurgery scores. Monitoring of this type of function is recommended after the procedure.

17.
Av. odontoestomatol ; 33(1): 33-40, ene.-feb. 2017. graf, tab
Artigo em Espanhol | IBECS | ID: ibc-160775

RESUMO

Objetivos: Los autores realizaron un ensayo clínico, aleatorizado, ciego simple, en el cual se determinó la eficacia del bloqueo del nervio infraorbitario en la anestesia de premolares maxilares comparándola con la técnica alveolar media superior. Materiales y métodos: Treinta sujetos voluntarios recibieron 1,8 mililitros de lidocaína al 2% con epinefrina 1:80.000. Los investigadores evaluaron el grado de anestesia pulpar con vitalómetro, dolor a la punción, inicio y duración del efecto anestésico, anestesia de tejidos blandos y comodidad del paciente ante esta anestesia. Los datos se analizaron usando la prueba de Shapiro Wilk, Mann-Whitney y McNemar. Resultados: La anestesia pulpar profunda en la técnica alveolar media fue significativamente mayor al compararla con la técnica infraorbitaria en el primer y segundo premolar, siendo del 95,2% y 100% respectivamente para la técnica alveolar media y del 66,7% y 42,9% en la técnica infraorbitaria. Los autores notaron significancia estadística en cuanto a la percepción del dolor asociado a la inyección, siendo la técnica infraorbitaria más dolorosa (p= 0,003). El inicio del efecto anestésico fue más corto después de aplicar la técnica alveolar media y la duración del efecto anestésico fue significativamente mayor en la misma técnica. La incidencia de anestesia subjetiva en labios, piel de ala nariz y encía fue del 100 % para la técnica infraorbitaria, reportando un mayor grado de incomodidad por la anestesia de los tejidos blandos en esta técnica. Conclusiones: La técnica alveolar media superior demostró ser más eficaz en la anestesia pulpar de premolares superiores al compararla la técnica infraorbita (AU)


Objective: The authors conducted a clinical trial, randomized, single blind to compare the efficacy of the infraorbital nerve block with the middle superior alveolar technique in achieving pulpal anesthesia of maxillary premolars. Material and Methods: Thirty volunteers subjects received 1.8 milliliter of 2 percent of lidocaine with 1:80.000 epinephrine. Researchers assessed the degree of pulpal anesthesia with an electronic pulp testing, puncture pain, soft-tissue anesthesia and patient comfort at this anesthesia, start time and duration of anesthetic effect. The data was analyzed by using the Shapiro-Wilk, Mann-Whiitney and McNemar tests. Results: Pulpal anesthesia deep in the middle superior alveolar technique was significantly higher when compared to the infraorbital technique in the first and second premolar, this being 95.2% and 100% respectively for the middle superior alveolar technique and 66.7% and 42.9% in the infraorbital technique. The authors noted statistical significance in the perception of pain associated with the injection, the most painful technique was the infraorbital (p= 0.003). The onset of the anesthetic effect was shorter after applying the middle superior alveolar technique and the duration of anesthetic effect was significantly higher in the same technique. The incidence of subjective anesthesia of lips, skin, wing nose and gum was 100% for the infraorbital technique, reporting greater discomfort for the soft tissue anesthesia in this technique. Conclusions: The middle alveolar superior technique proved more effective in achieving pulpal anesthesia of maxillary premolars with respect to the infraorbital technique (AU)


Assuntos
Humanos , Bloqueio Nervoso/métodos , Anestesia Dentária/métodos , Anestesia Local/métodos , Lidocaína/administração & dosagem , Epinefrina/administração & dosagem , Nervo Mandibular , Nervo Maxilar , Anestésicos Locais/administração & dosagem
19.
J Med Life ; 10(4): 237-243, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29362599

RESUMO

The objective of the study was to assess the clinical, histopathological and immunochemical changes induced by dialyzable leukocyte extract (DLE) treatment in patients with chronic cervicitis associated to HPV infection. Fifty-four female Mexican patients diagnosed with chronic cervicitis, cervical intra-epithelial neoplasia grade 1 (CIN 1) and HPV infection were divided into two groups: patients treated with placebo and patients treated with DLE. Clinical and colposcopy evaluations were performed before and after treatments. Cervix biopsies were obtained to analyze histopathological features and to determine the local immunological changes by immunohistochemistry analyses. Placebo-treated patients showed no significant changes in the evaluated parameters. Interestingly, in DLE-treated patients, clinical manifestations of cervicitis diminished and 89% of them remitted the colposcopic lesions. Histological analyses of biopsies from DLE-treated patients showed a decreasing leukocyte infiltrate. Immunochemical analyses showed an increased expression of TGF-ß, while expression of IFN-γ, PCNA, and IL-32 decreased. Our results suggest that DLE can stimulate innate immunity of cervical mucosae, diminishing chronic cervicitis in HPV-infected patients. TRIAL REGISTRATION: Register ISRCTN16429164 Abbreviations: HPV = Human Papilloma Virus; DLE = Dialyzable leukocyte extract.


Assuntos
Infecções por Papillomavirus/complicações , Fator de Transferência/uso terapêutico , Cervicite Uterina/complicações , Cervicite Uterina/tratamento farmacológico , Adulto , Idoso , Biópsia , Colo do Útero/diagnóstico por imagem , Colo do Útero/patologia , Doença Crônica , Colposcopia , Feminino , Humanos , Imuno-Histoquímica , Interferon gama/metabolismo , Interleucinas/metabolismo , Pessoa de Meia-Idade , Infecções por Papillomavirus/virologia , Antígeno Nuclear de Célula em Proliferação/metabolismo , Fator de Crescimento Transformador beta/metabolismo , Cervicite Uterina/diagnóstico por imagem , Cervicite Uterina/patologia , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...